Luminex's Q1 Revenues Rise 9 Percent on Jump in Royalties, Assay Sales | GenomeWeb

NEW YORK (GenomeWeb News) – Luminex reported after the close of the market Monday that its first-quarter 2013 revenues increased 9 percent, driven by a 23 percent increase in royalty revenues year over year and a jump in assay sales.

Austin, Texas-based Luminex brought in total revenues of $53.2 million for the three months ended March 31, compared to revenues of $48.7 million for the first quarter of 2012. It beat the consensus Wall Street estimate for revenues of $52 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.

A man is using DNA evidence to argue that he is the rightful heir to the baronetcy of Stichill, the Guardian reports.

As part of an effort to get a diverse group of people to donate their DNA for research, some blood donors in the San Diego area will get their genomes sequenced, according to KPBS.

The comment period on the Department of Health and Human Services' proposal to alter the Common Rule has been extended.